Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

The Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic Cancers.

Kenmogne LC, Ayan D, Roy J, Maltais R, Poirier D.

PLoS One. 2015 Dec 14;10(12):e0144890. doi: 10.1371/journal.pone.0144890. eCollection 2015.

2.

Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance.

Jones SK, Lizzio V, Merkel OM.

Biomacromolecules. 2016 Jan 11;17(1):76-87. doi: 10.1021/acs.biomac.5b01189. Epub 2015 Dec 16.

3.

Indium-Labeling of siRNA for Small Animal SPECT Imaging.

Jones S, Merkel O.

Methods Mol Biol. 2016;1372:79-88. doi: 10.1007/978-1-4939-3148-4_6.

4.

ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice.

Shoemaker R, Yiannikouris F, Thatcher S, Cassis L.

Am J Physiol Endocrinol Metab. 2015 Oct 1;309(7):E621-31. doi: 10.1152/ajpendo.00054.2015. Epub 2015 Aug 4.

5.

BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.

Wang ZQ, Faddaoui A, Bachvarova M, Plante M, Gregoire J, Renaud MC, Sebastianelli A, Guillemette C, Gobeil S, Macdonald E, Vanderhyden B, Bachvarov D.

Oncotarget. 2015 Oct 13;6(31):31522-43. doi: 10.18632/oncotarget.5159.

6.

Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis.

Leech AO, Cruz RG, Hill AD, Hopkins AM.

Ann Transl Med. 2015 Aug;3(13):184. doi: 10.3978/j.issn.2305-5839.2015.08.01. Review.

7.

Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells.

Jimbo M, Blanco FF, Huang YH, Telonis AG, Screnci BA, Cosma GL, Alexeev V, Gonye GE, Yeo CJ, Sawicki JA, Winter JM, Brody JR.

Oncotarget. 2015 Sep 29;6(29):27312-31. doi: 10.18632/oncotarget.4743.

8.

Down Regulation of CLDND1 Induces Apoptosis in Breast Cancer Cells.

Achari C, Winslow S, Larsson C.

PLoS One. 2015 Jun 17;10(6):e0130300. doi: 10.1371/journal.pone.0130300. eCollection 2015.

9.

The effects of claudin 14 during early Wallerian degeneration after sciatic nerve injury.

Gong L, Zhu Y, Xu X, Li H, Guo W, Zhao Q, Yao D.

Neural Regen Res. 2014 Dec 15;9(24):2151-8. doi: 10.4103/1673-5374.147946.

10.

CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling.

Baldwin LA, Hoff JT, Lefringhouse J, Zhang M, Jia C, Liu Z, Erfani S, Jin H, Xu M, She QB, van Nagell JR, Wang C, Chen L, Plattner R, Kaetzel DM, Luo J, Lu M, West D, Liu C, Ueland FR, Drapkin R, Zhou BP, Yang XH.

Oncotarget. 2014 Dec 15;5(23):12203-17.

11.

Small RNA combination therapy for lung cancer.

Xue W, Dahlman JE, Tammela T, Khan OF, Sood S, Dave A, Cai W, Chirino LM, Yang GR, Bronson R, Crowley DG, Sahay G, Schroeder A, Langer R, Anderson DG, Jacks T.

Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):E3553-61. doi: 10.1073/pnas.1412686111. Epub 2014 Aug 11.

12.

Androgen-dependent sertoli cell tight junction remodeling is mediated by multiple tight junction components.

Chakraborty P, William Buaas F, Sharma M, Smith BE, Greenlee AR, Eacker SM, Braun RE.

Mol Endocrinol. 2014 Jul;28(7):1055-72. doi: 10.1210/me.2013-1134. Epub 2014 May 13.

13.

Claudin and ovarian cancer.

Bose CK, Mukhopadhyay A.

J Turk Ger Gynecol Assoc. 2010 Mar 1;11(1):48-54. eCollection 2010. Review.

14.

Liposome-like Nanostructures for Drug Delivery.

Gao W, Hu CM, Fang RH, Zhang L.

J Mater Chem B Mater Biol Med. 2013 Dec 28;1(48). doi: 10.1039/C3TB21238F.

15.

Emerging roles of claudins in human cancer.

Kwon MJ.

Int J Mol Sci. 2013 Sep 4;14(9):18148-80. doi: 10.3390/ijms140918148. Review.

16.

Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms.

Jones PM, Drapkin R.

Front Oncol. 2013 Aug 26;3:217. doi: 10.3389/fonc.2013.00217. eCollection 2013.

17.

Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy.

English DP, Santin AD.

Int J Mol Sci. 2013 May 17;14(5):10412-37. doi: 10.3390/ijms140510412. Review.

18.

Lipid-like Nanoparticles for Small Interfering RNA Delivery to Endothelial Cells.

Cho SW, Goldberg M, Son SM, Xu Q, Yang F, Mei Y, Bogatyrev S, Langer R, Anderson DG.

Adv Funct Mater. 2009 Oct 9;19(19):3112-3118. Epub 2009 Aug 25.

19.

Neutral polymeric micelles for RNA delivery.

Lundy BB, Convertine A, Miteva M, Stayton PS.

Bioconjug Chem. 2013 Mar 20;24(3):398-407. doi: 10.1021/bc300486k. Epub 2013 Feb 22.

20.

Lipid-based vectors for siRNA delivery.

Zhang S, Zhi D, Huang L.

J Drug Target. 2012 Nov;20(9):724-35. doi: 10.3109/1061186X.2012.719232. Epub 2012 Sep 20. Review.

Supplemental Content

Support Center